Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

News Conference News HRS 2025

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

May 02, 2025

PRAETORIAN-XL: Fewer Major, Lead-Related Problems With Subcutaneous ICD

News Conference News HRS 2025

PRAETORIAN-XL: Fewer Major, Lead-Related Problems With Subcutaneous ICD

April 29, 2025

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

February 21, 2025

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

Ultralow-Temperature Cryoablation Promising for Monomorphic VT

News Conference News EHRA 2024

Ultralow-Temperature Cryoablation Promising for Monomorphic VT

April 12, 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

PCI Doesn’t Cut Arrhythmias in Severe LV Dysfunction: REVIVED-BCIS2 Analysis

News Daily News

PCI Doesn’t Cut Arrhythmias in Severe LV Dysfunction: REVIVED-BCIS2 Analysis

August 14, 2023

Synchronized LV Pacing Not Superior to Conventional CRT in Heart Failure

News Conference News EHRA 2023

Synchronized LV Pacing Not Superior to Conventional CRT in Heart Failure

Michael O'Riordan

April 18, 2023

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

News Conference News THT 2023

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

March 21, 2023

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

News Daily News

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Michael O'Riordan

January 30, 2023

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

December 20, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.